These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7622346)

  • 1. Serotonin and suicidality: the impact of fluoxetine administration. II: Acute neurobiological effects.
    Anderson GM; Segman RH; King RA
    Isr J Psychiatry Relat Sci; 1995; 32(1):44-50. PubMed ID: 7622346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and suicidality: the impact of acute fluoxetine administration. I: Serotonin and suicide.
    King RA; Segman RH; Anderson GM
    Isr J Psychiatry Relat Sci; 1994; 31(4):271-9. PubMed ID: 7875951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine].
    Le Poul E; Lima L; Laporte AM; Even C; Doucet E; Fattaccini CM; Laaris N; Hamon M; Lanfumey L
    Encephale; 1995; 21(2):123-32. PubMed ID: 7781583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections.
    Taber MT; Kinney GG; Pieschl RL; Yocca FD; Gribkoff VK
    Synapse; 2000 Oct; 38(1):17-26. PubMed ID: 10941137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akathisia, suicidality, and fluoxetine.
    Hamilton MS; Opler LA
    J Clin Psychiatry; 1992 Nov; 53(11):401-6. PubMed ID: 1364815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons.
    Zhong P; Yan Z
    Neuroscience; 2004; 129(1):65-73. PubMed ID: 15489029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flesinoxan challenge suggests that chronic treatment with paroxetine in rats does not desensitize receptors controlling 5-HT synthesis.
    Skelin I; Yamane F; Diksic M
    Neurochem Int; 2008 Dec; 53(6-8):236-43. PubMed ID: 18786747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
    Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
    Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential characteristics of endogenous serotonin-mediated synaptic transmission in the hippocampal CA1 and CA3 fields of anaesthetized rats.
    Matsumoto M; Kojima T; Togashi H; Mori K; Ohashi S; Ueno K; Yoshioka M
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):570-7. PubMed ID: 12444499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin syndrome.
    Ivanusa Z; Hećimović H; Demarin V
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Jul; 10(3):209-12. PubMed ID: 9297715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
    Klimek V; Zak-Knapik J; Mackowiak M
    J Psychiatry Neurosci; 1994 Jan; 19(1):63-7. PubMed ID: 8148368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular electrophysiological effects of chronic fluoxetine and duloxetine administration on serotonergic responses in the aging hippocampus.
    Smith JE; Lakoski JM
    Synapse; 1998 Nov; 30(3):318-28. PubMed ID: 9776135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of serotonin transmission in schizophrenia.
    Abi-Dargham A
    Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alcohol and the serotonin system].
    Daoust M; Ernouf D; Narcisse G
    Ann Med Psychol (Paris); 1992; 150(2-3):143-6. PubMed ID: 1343508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine-induced suicidality, serotonin, and seasonality.
    Brewerton TD
    Biol Psychiatry; 1991 Jul; 30(2):190-6. PubMed ID: 1912109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical effects of fluoxetine.
    Gualtieri CT
    J Clin Psychopharmacol; 1991 Dec; 11(6):393-4. PubMed ID: 1663135
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of ethanol on cultured fetal serotonergic neurons.
    Lokhorst DK; Druse MJ
    Alcohol Clin Exp Res; 1993 Feb; 17(1):86-93. PubMed ID: 8383927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.